INVASIVE LOBULAR BREAST CARCINOMA

This adverse event was reported 513 times

These drugs are most commonly taken by patients reporting INVASIVE LOBULAR BREAST CARCINOMA:

# Drug Count
0 LETROZOLE 72
1 LETROZOLE TABLETS 65
2 CYCLOPHOSPHAMIDE 60
3 CYCLOPHOSPHAMIDE FOR INJECTION 60
4 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 60
5 FULVESTRANT 42
6 EXEMESTANE 40
7 METHOTREXATE SODIUM 39
8 DENOSUMAB 38
9 METHOTREXATE 35
See all common drugs associated with INVASIVE LOBULAR BREAST CARCINOMA

INVASIVE LOBULAR BREAST CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VINBLASTINE SULFATE 7 0.0036
1 EXEMESTANE 40 0.0019
2 GOSERELIN 23 0.0017
3 LETROZOLE TABLETS 65 0.0013
4 FULVESTRANT 42 0.0013
5 LETROZOLE 72 0.0012
6 DACARBAZINE 8 0.0011
7 ANASTROZOLE TABLETS 21 0.0010
8 ERGOCALCIFEROL 28 0.0009
9 RIBOCICLIB 30 0.0009
See all drugs enriched for association with INVASIVE LOBULAR BREAST CARCINOMA

INVASIVE LOBULAR BREAST CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 42 0.0010
1 Aromatase Inhibitor [EPC] 105 0.0009
2 Estrogen Agonist/Antagonist [EPC] 1 0.0004
3 Antimalarial [EPC] 4 0.0004
4 Antiprotozoal [EPC] 4 0.0004
5 Microtubule Inhibitor [EPC] 45 0.0003
6 Amyloid Beta-directed Antibody [EPC] 1 0.0003
7 Alkylating Drug [EPC] 60 0.0002
8 Antiparasitic [EPC] 1 0.0002
9 Pediculicide [EPC] 1 0.0002
See all drug classes enriched for association with INVASIVE LOBULAR BREAST CARCINOMA